We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ADDV-B.ST

Price
1.61
Stock movement down
-0.04 (-2.48%)
Company name
ADDvise Group B
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
916.80M
Ent value
3.23B
Price/Sales
0.56
Price/Book
1.17
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
8.01
Forward P/E
5.73
PEG
-
EPS growth
-
1 year return
-79.53%
3 year return
-38.54%
5 year return
10.14%
10 year return
-
Last updated: 2025-08-27

DIVIDENDS

ADDV-B.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E8.01
Price to OCF14.33
Price to FCF50.37
Price to EBITDA2.59
EV to EBITDA9.14

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.56
Price to Book1.17
EV to Sales1.99

FINANCIALS

Per share

Loading...
Per share data
Current share count583.21M
EPS (TTM)0.58
FCF per share (TTM)0.09

Income statement

Loading...
Income statement data
Revenue (TTM)1.63B
Gross profit (TTM)409.70M
Operating income (TTM)264.10M
Net income (TTM)114.40M
EPS (TTM)0.58
EPS (1y forward)0.27

Margins

Loading...
Margins data
Gross margin (TTM)25.19%
Operating margin (TTM)16.24%
Profit margin (TTM)7.03%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash278.10M
Net receivables391.90M
Total current assets921.90M
Goodwill1.53B
Intangible assets711.70M
Property, plant and equipment0.00
Total assets3.37B
Accounts payable116.60M
Short/Current long term debt1.73B
Total current liabilities566.40M
Total liabilities2.59B
Shareholder's equity782.00M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)64.00M
Capital expenditures (TTM)45.80M
Free cash flow (TTM)18.20M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity14.63%
Return on Assets3.39%
Return on Invested Capital13.10%
Cash Return on Invested Capital2.08%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.61
Daily high1.61
Daily low1.55
Daily Volume766K
All-time high16.82
1y analyst estimate2.50
Beta-0.11
EPS (TTM)0.58
Dividend per share-
Ex-div date26 Apr 2021
Next earnings date23 Oct 2025

Downside potential

Loading...
Downside potential data
ADDV-B.STS&P500
Current price drop from All-time high-90.42%-2.53%
Highest price drop-93.52%-56.47%
Date of highest drop9 Apr 20259 Mar 2009
Avg drop from high-50.67%-11.04%
Avg time to new high49 days12 days
Max time to new high1484 days1805 days
COMPANY DETAILS
ADDV-B.ST (ADDvise Group B) company logo
Marketcap
916.80M
Marketcap category
Small-cap
Description
ADDvise Group AB (publ) supplies medical devices, equipment, and consumables to public and private laboratories and research facilities, healthcare, and pharmaceuticals in North America, Europe, South America, Sweden, and internationally. The company provides laboratory furniture, protective ventilation systems, climate-controlled clean rooms, and laboratory equipment; and develops and supplies medical equipment, consumables, and pharmaceuticals in areas, such as urology, gynecology, emergency care, and surgery. It is also involved in rental and sale of medical equipment; distributes specialized instruments, consumables, and services in the life-science and biopharma sectors; designing, constructing, and installing customized cleanrooms and air conditioning systems; distributes glucose monitors and insulin pumps for diabetic patients; develops, manufactures, and markets products for rescue, ambulance, healthcare, and rehabilitation operations. In addition, the company offers implants, instruments, and technologies for surgical precision and patient; disposable medical devices, cables, connectors, wires, CO2 indicators, ultrasound device, patient positioning equipment, and surgical tables; develops software and instruments for patient mobility, pain, and muscle strength to rehabilitate muscular conditions, as well as to streamline the monitoring of vital signs in patients in long-term care and nursing homes; operates mail-order pharmacy specializing in men's health medications for treating cancer, incontinence, and impotence; develops, manufactures, and markets over-the-counter generic drugs for pain management and for the treatment of coughs, colds, allergies, sinus infections, and urological conditions; and supplies glucose meter and test strip products. The company was formerly known as ADDvise Lab Solutions AB (publ). ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.
Employees
605
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
ADDvise Group AB (FRA:Q3I) reports robust cash flow and strategic debt reduction, despite facing currency headwinds and CapEx cycle softness.
July 18, 2025
Despite revenue growth and a successful rights issue, ADDvise Group AB faces margin pressures and macroeconomic uncertainties.
May 10, 2025
ADDvise Group AB (FRA:Q3I) reports an 11% increase in net sales, while addressing organic growth hurdles and strategic shifts in its healthcare and lab segments.
February 21, 2025